KYMERA

EUIPO EUIPO 2021 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark KYMERA was filed as Figurative mark on 03/05/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 08/27/2021. The current status of the mark is "Trademark registered".

Logodesign (Wiener Klassifikation)

#Backgrounds, in words or numerals, divided into two, vertically #Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded corners #Several quadrilaterals juxtaposed, joined or intersecting #White, grey, silver #Orange

Trademark Details Last update: February 8, 2024

Trademark form Figurative mark
File reference 018418223
Application date March 5, 2021
Publication date March 12, 2021
Entry date August 27, 2021
Expiration date March 5, 2031

Trademark owner

300 Technology Square, 2nd Floor
02139 Cambridge
US

Trademark representatives

Avenue Louise 480/13A 1050 Brussels BE

Objection / Complaint

06/11/2021: Likelihood of confusion
Trademark
Applicant
Idorsia Pharmaceuticals Ltd

goods and services

5 Pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune-oncology and other related diseases; Pharmaceutical and medical therapeutics for the treatment of oncology, autoimmune, immune-oncology and other related diseases; Diagnostic reagents for the treatment of oncology, autoimmune, immune-oncology and other related diseases
42 Research and development of therapeutic drugs for the treatment of oncology, autoimmune, immune-oncology and other related diseases; research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies, pharmaceuticals and biopharmaceuticals; development of pharmaceutical preparations and medicines; drug development and discovery; medical research for development of therapeutic modalities for treatment of diseases; assays and reagents for use in scientific and biomedical research; clinical studies; preclinical and clinical development of therapeutic products

Trademark history

Date Document number Area Entry
November 9, 2021 Change Representative, Published

ID: 11018418223